Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 402472

Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment


Kraljević Pavelić, Sandra; Marjanović, Marko; Poznić, Miroslav; Kralj, Marijeta
Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment // Journal of Cancer Research and Clinical Oncology, 135 (2009), 12; 1747-1761 doi:10.1007/s00432-009-0621-5 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 402472 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment

Autori
Kraljević Pavelić, Sandra ; Marjanović, Marko ; Poznić, Miroslav ; Kralj, Marijeta

Izvornik
Journal of Cancer Research and Clinical Oncology (0171-5216) 135 (2009), 12; 1747-1761

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
p53; p21WAF1/CIP1; cell cycle; cyclin B1; HEp-2 cells; CAL 27 cells

Sažetak
Purpose: p53 gene plays a crucial role in the response to therapy. Since it is inactivated in the majority of human cancers, it is strongly believed that the p53 mutations confer resistance to therapeutics. In this paper we analyzed the influence of two mechanistically diverse antitumor agents – cisplatin and methotrexate on the proliferation and cell cycle of two head and neck squamous cancer cell lines HEp-2 (wild type p53 gene, but HPV 18/E6 - inactivated protein) and CAL 27 (mutated p53 gene), along with the influence of adenovirally-mediated p53 overexpression in modulation of cisplatin and methoterexate effects, whereby subtoxic vector/compound concentrations were employed. Methods: p53 gene was introduced into tumor cells using adenoviral vector (AdCMV-p53). The cell cycle perturbations were measured by two parameter flow cytometry. The expression of p53, p21WAF1/CIP1 and cyclin B1 proteins was examined using immunocytochemistry and Western blot methods. Results: In CAL 27 cells overexpression of p53 completely abrogated high S phase content observed in methotrexate-treated cells into a G1 and slight G2 arrest, while it sustained G2 arrest of the cells treated with cisplatin, along with the reduction of DNA synthesis and cyclin B1 expression. On the other hand, in HEp-2 cell line p53 overexpression sustained G1/S arrest in cells treated with methotrexate and decreased the cyclin B1 expression, but failed to sustain the G2 arrest after treatment with cisplatin alone. Instead, it increased the population of S phase cells that weren’ t actively synthesizing DNA, sustained cyclin B1 expression and allowed the G2 cells to progress through mitosis. Conclusions: This study demonstrates that adenovirally-mediated p53 overexpression at sub-cytotoxic levels enhanced the activity of low doses of cisplatin and methotrexate in HEp-2 and CAL 27 cells through changes in the cell cycle. However, the mechanisms of these effects differ depending on the genetic context and on the chemotherapeutics’ modality of action.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti

Napomena
Prva dva autora su jednako doprinjela radu. First two authors have contributed equally to this work.



POVEZANOST RADA


Projekti:
098-0982464-2393 - Molekularna obilježja miofibroblasta Dupuytrenove bolesti
098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Kraljević Pavelić, Sandra; Marjanović, Marko; Poznić, Miroslav; Kralj, Marijeta
Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment // Journal of Cancer Research and Clinical Oncology, 135 (2009), 12; 1747-1761 doi:10.1007/s00432-009-0621-5 (međunarodna recenzija, članak, znanstveni)
Kraljević Pavelić, S., Marjanović, M., Poznić, M. & Kralj, M. (2009) Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment. Journal of Cancer Research and Clinical Oncology, 135 (12), 1747-1761 doi:10.1007/s00432-009-0621-5.
@article{article, author = {Kraljevi\'{c} Paveli\'{c}, Sandra and Marjanovi\'{c}, Marko and Pozni\'{c}, Miroslav and Kralj, Marijeta}, year = {2009}, pages = {1747-1761}, DOI = {10.1007/s00432-009-0621-5}, keywords = {p53, p21WAF1/CIP1, cell cycle, cyclin B1, HEp-2 cells, CAL 27 cells}, journal = {Journal of Cancer Research and Clinical Oncology}, doi = {10.1007/s00432-009-0621-5}, volume = {135}, number = {12}, issn = {0171-5216}, title = {Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment}, keyword = {p53, p21WAF1/CIP1, cell cycle, cyclin B1, HEp-2 cells, CAL 27 cells} }
@article{article, author = {Kraljevi\'{c} Paveli\'{c}, Sandra and Marjanovi\'{c}, Marko and Pozni\'{c}, Miroslav and Kralj, Marijeta}, year = {2009}, pages = {1747-1761}, DOI = {10.1007/s00432-009-0621-5}, keywords = {p53, p21WAF1/CIP1, cell cycle, cyclin B1, HEp-2 cells, CAL 27 cells}, journal = {Journal of Cancer Research and Clinical Oncology}, doi = {10.1007/s00432-009-0621-5}, volume = {135}, number = {12}, issn = {0171-5216}, title = {Adenovirally-mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment}, keyword = {p53, p21WAF1/CIP1, cell cycle, cyclin B1, HEp-2 cells, CAL 27 cells} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font